Zoetis Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Explore the Complete Value Chain Behind the Preview
This Zoetis Value Chain Analysis helps you understand the company's support and primary activities in one clear framework. This page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to access the complete ready-to-use report.
Support Activities
Firm Infrastructure
Zoetis keeps firm infrastructure central to its animal-health scale: in 2025 it served customers in more than 100 countries, with finance, legal, regulatory, quality, and risk teams helping move products across companion-animal and livestock markets. This control layer supports approvals, audit readiness, and capital allocation, so R&D and commercial spend stay tied to the highest-return programs. One clear sign of scale: Zoetis reported about $9.3 billion in 2025 revenue.
Human Resource Management
Zoetis's human resource management relies on scientists, manufacturing specialists, veterinarians, and commercial teams with deep animal-health skills. Ongoing GMP, product-safety, and customer-support training helps protect quality and trust across a portfolio that served veterinarians and livestock producers in 2025 with $9.3 billion in revenue and about 13,800 employees.
Technology Development
Zoetis' Technology Development backs medicines, vaccines, diagnostics, genetic tests, and biodevices, with FY2025 R&D keeping the pipeline fresh. In 2025, Zoetis reported about $9.3 billion in revenue and invested roughly $0.6 billion in R&D, helping defend pricing and support launches in regulated animal-health categories. That spend matters because differentiated products and faster label wins can lift margins and reduce share loss.
Procurement
Zoetis manages procurement of active ingredients, biological materials, packaging, lab inputs, and manufacturing services under tight supplier controls. In fiscal 2025, Zoetis reported about $9.3 billion in revenue, so buying quality inputs is central to keeping output stable.
Strong procurement helps protect cold-chain integrity, reduce batch risk, and keep global sites supplied on time.
Zoetis' 2025 Scale Powers Global Growth
Zoetis' support activities in 2025 were built around scale: about 13,800 employees, roughly $9.3 billion revenue, and about $0.6 billion R&D spend. That base supports finance, compliance, talent, tech, and sourcing across 100+ countries, helping keep regulated launches, quality control, and supply reliability on track.
| 2025 metric | Value |
|---|---|
| Revenue | $9.3B |
| R&D | $0.6B |
| Employees | 13,800 |
| Markets | 100+ |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Zoetis inbound logistics relies on a tightly controlled supply chain for raw materials, biological inputs, packaging, and device parts, because many inputs must stay within strict temperature limits. In 2025, Zoetis reported about $9.3 billion in revenue, so even small disruptions in incoming quality checks or cold-chain handling can affect a very large sales base. This matters most for vaccines and biologics, where incoming inspection and lot traceability help protect product quality and regulatory compliance.
Operations
Zoetis turns research into medicines, vaccines, diagnostics, and related products through formulation, filling, finishing, and testing. In 2025, Zoetis reported $9.3 billion in revenue and spent $649 million on R&D, so operations must scale fast without losing quality. Batch release, documentation, and quality systems help Zoetis serve livestock and companion-animal markets across more than 100 countries.
Outbound Logistics
Zoetis moves finished products through wholesalers, veterinary channels, and direct customer networks, so outbound logistics must keep clinics, farms, and companion-animal practices stocked on time. In 2025, Zoetis served customers in more than 100 countries, which makes cold-chain handling and tight inventory planning critical for biologics and other temperature-sensitive products. Strong delivery execution supports service levels across a global mix of livestock and pet demand.
Marketing and Sales
Zoetis sells through veterinarians, field teams, technical education, and account managers for large clinics, so approvals can turn into repeat orders. Its 2025 marketing and sales work leans on strong brands and evidence-based selling, which helps support durable demand across companion animal and livestock lines. The model works because Zoetis pairs product promotion with training and customer support, not just price.
Service
Zoetis service backs dosing guidance, technical help, adverse-event reporting, and diagnostics support, so vets and producers get help after the sale. In 2025, that matters because Zoetis sold into more than 100 countries, where fast follow-up can protect animal health and repeat use. Service also helps cut treatment errors and keeps trust high in long-term livestock and pet care.
One clear sign of the value: post-sale support can turn a one-time product sale into an ongoing relationship.
Zoetis' 2025: R&D-Driven Animal Health With Global Reach
Zoetis' primary activities turn R&D-heavy animal health products into global sales, delivery, and post-sale support. In 2025, it generated about $9.3 billion in revenue, spent $649 million on R&D, and served customers in more than 100 countries, so manufacturing quality, channel reach, and technical service all drive value.
| Metric | 2025 |
|---|---|
| Revenue | $9.3 billion |
| R&D | $649 million |
| Countries served | 100+ |
Preview the Actual Deliverable
Zoetis Reference Sources
This is the actual Zoetis Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so you're seeing the same content included in the final download. Purchase unlocks the complete, in-depth version.
Frequently Asked Questions
Zoetis creates value by linking R&D, regulated manufacturing, distribution, and field support into one operating system. In 2024 Zoetis generated about $9.3 billion in revenue, employed roughly 13,800 people, and sold in more than 100 countries and territories, so scale only works when quality and compliance stay tight.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.